HS830 Unit 5 Autism Prevalence Seminar Reflection Example

One in Thirty-One, Compared With When? A Unit 5 Seminar Reflection on Separating a Common Condition From a Rising One

[Student Name]

Purdue University Global

HS830: Advanced Health Issues and Trends

Unit 5 Seminar Reflection

[Instructor Name]

[Date]

The seminar and classmates are composite and described by role; the surveillance figures and studies cited are real.

The Position I Carried In

My discussion post that week argued that autism was rising faster than any other childhood developmental condition and that health systems should plan for an accelerating epidemic. The evidence seemed simple. The Autism and Developmental Disabilities Monitoring (ADDM) Network estimated that 1 in 31 children aged eight had been identified with autism in 2022, up from 1 in 36 two years earlier (Maenner et al., 2023; Shaw et al., 2025). The network's first estimate, for 2000, had been about 1 in 150. A fivefold rise in two decades looked like the clearest trend in pediatric health. I wrote the word epidemic in my first sentence and meant it as a description of incidence.

Moment One: A Nurse Who Screens

The school nurse spoke first. Her district had begun working with pediatric practices that follow the recommendation to screen every child for autism at 18 and 24 months, and she described how many children now arrive at kindergarten already identified, compared with the early years of her career, when diagnosis often came in third or fourth grade, if at all. Her question was not whether autism was common but what the ADDM number counts. I had to look it up during the break. ADDM does not examine children; it reviews health and education records at its sites and counts children whose records document an autism diagnosis, a special education classification or a recorded evaluation. Every improvement in screening, diagnosis and school classification raises the count, whether or not more children are autistic.

A surveillance count built from records can only rise as fast as the system that creates the records, and for two decades that system has been expanding.

That changed my reading of the rise from 1 in 36 to 1 in 31. Two years is too short for a biological shift of that size, but not too short for wider screening and faster evaluation to show up in records. The 2025 report itself noted that identification by age four had risen in the younger cohort, which is what earlier detection, not more cases, would produce (Shaw et al., 2025).

Moment Two: A Classmate From Adult Services

The second moment came from a classmate who coordinates services for adults with developmental disabilities. She pointed out that adults diagnosed in their thirties and forties are now a large share of new referrals in her agency, people who were children when the count was 1 in 150. If autism had truly been rare in 2000, she asked, where did they come from? I checked this against the research the seminar leader posted afterward. A Danish birth cohort study estimated that about 60 percent of the increase in autism prevalence there could be explained by changes in diagnostic criteria and by the inclusion of outpatient diagnoses in the national registry (Hansen et al., 2015). An earlier analysis of U.S. special education data found that rising autism classifications were accompanied by falling classifications for intellectual disability and learning disability, a pattern consistent with diagnostic substitution (Shattuck, 2006). Neither study rules out a true increase; both show that much of the measured rise reflects counting.

Moment Three: My Revision

The third moment was mine. The seminar leader asked each of us to restate our position in one sentence that the evidence could carry. My first attempt kept the word epidemic. A classmate asked me to define it, and I could not do so without claiming rising incidence, which the session had just shown I could not support. My revised sentence was that autism is common, that identified prevalence has risen sharply, and that most of the rise documented so far is better explained by wider criteria, earlier screening and better records than by more children becoming autistic, with a residual increase that remains uncertain.

That revision also changed where I think a health system's attention belongs. The ADDM report found that identification was now higher among Asian or Pacific Islander, Black and Hispanic children than among White children, reversing the pattern of earlier reports, and that prevalence varied severalfold across sites, which is itself a sign that identification practices drive the numbers (Shaw et al., 2025). The planning problem is not an accelerating epidemic but a backlog: more children and adults are now identified than evaluation and support services were built to handle.

What I Now Defend

I defend three claims. Autism is common, affecting about 3 percent of eight-year-olds identified at ADDM sites. Measured prevalence has risen steeply and is likely to keep rising as screening reaches more children and adults. Whether the underlying incidence has risen, and by how much, is not settled by surveillance counts and needs studies designed to separate detection from occurrence. I dropped epidemic, because it asserts the one thing the evidence cannot yet show.

The question I hand to next week's counterargument unit is whether wait times for diagnostic evaluation have grown faster than the identified population, because if they have, the issue a health science leader should rank is not the count but the capacity behind it. The seminar did not change my view that autism belongs on a list of issues facing health systems. It changed which part of the issue I would put in front of a leader.

References

Hansen, S. N., Schendel, D. E., & Parner, E. T. (2015). Explaining the increase in the prevalence of autism spectrum disorders: The proportion attributable to changes in reporting practices. JAMA Pediatrics, 169(1), 56-62. https://doi.org/10.1001/jamapediatrics.2014.1893

Maenner, M. J., Warren, Z., Williams, A. R., Amoakohene, E., Bakian, A. V., Bilder, D. A., Durkin, M. S., Fitzgerald, R. T., Furnier, S. M., Hughes, M. M., Ladd-Acosta, C. M., McArthur, D., Pas, E. T., Salinas, A., Vehorn, A., Williams, S., Esler, A., Grzybowski, A., Hall-Lande, J., ... Shaw, K. A. (2023). Prevalence and characteristics of autism spectrum disorder among children aged 8 years: Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020. MMWR Surveillance Summaries, 72(2), 1-14. https://doi.org/10.15585/mmwr.ss7202a1

Shattuck, P. T. (2006). The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education. Pediatrics, 117(4), 1028-1037. https://doi.org/10.1542/peds.2005-1516

Shaw, K. A., Williams, S., Patrick, M. E., Valencia-Prado, M., Durkin, M. S., Howerton, E. M., Ladd-Acosta, C. M., Pas, E. T., Bakian, A. V., Bartholomew, P., Nieves-Muñoz, N., Sidwell, K., Alford, A., Bilder, D. A., DiRienzo, M., Fitzgerald, R. T., Furnier, S. M., Hudson, A. E., Pokoski, O. M., ... Maenner, M. J. (2025). Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years: Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveillance Summaries, 74(2), 1-22. https://doi.org/10.15585/mmwr.ss7402a1